Efficacy of praziquantel correlated to disease burden?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1229, 2000-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Pharmacological Treatment of Neuropsychiatric Symptoms in Alzheimer's Disease Relieve Caregiver Burden?

By Levy Karen   Lanctôt Krista L.   Farber Shale B.   Li Abby   Herrmann Nathan  

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 167-179

Adis International

Access to resources Recommend Favorite

The Economic Impact of Neuropsychiatric Symptoms in Alzheimer’s Disease: Can Drugs Ease the Burden?

By Murman Daniel L.  

PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. : 227-242

Adis International

Access to resources Recommend Favorite

Pneumococcal Disease in the Elderly: What is Preventing Vaccine Efficacy?

By Rubins J.B.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 305-311

Adis International

Access to resources Recommend Favorite

Are there efficacy differences between antihypertensives?

By  

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Naltrexone: efficacy in alcohol relapse?

By  

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite